Years of research have showed that pulse oximeters yield less accurate readings for people with darker skin tones, and now ...

The temporary pause follows reports of four cases of neurovascular events in the US external evaluation study.

Johnson & Johnson pauses U.S. Varipulse cases to investigate neurovascular events. The FDA-approved device integrates PFA ...

“On January 5, out of an abundance of caution, Johnson & Johnson MedTech temporarily paused the U.S. External Evaluation and ...

Aesthetic physician Dr Farzan Iqbal finds the perfect match for his fast-paced, stylish urban lifestyle in the all-electric ...

The city’s public hospital system has agreed to resume contract talks with nearly 1,000 of its doctors this week in hopes of ...

"The geography was right for us," Mark O'Halla, CEO of Prisma Health, told Becker's. "Our goal is to grow into a regional health system across North Carolina, South Carolina, Georgia and Tennessee." ...

The Saskatchewan Health Authority (SHA) said contract nursing expenses over the 2023-24 fiscal year (April to March) was $89.8M. Is the plan working? It depends on who you ask.

The FDA approved subcutaneous nivolumab for solid tumors, tiselizumab for advanced gastric and GEJ cancers, and key 2024 breast cancer breakthroughs are reviewed. Experts provide perspective on ...

Just months after FDA approval, Johnson & Johnson paused the rollout of its Varipulse pulsed field ablation (PFA) platform in ...

By integrating advanced safety systems and continuously refining related protocols, companies can prioritize the safety of ...